Digital Fall Prevention for Falling
What You Need to Know Before You Apply
What is the purpose of this trial?
The aging of the U.S. population, combined with health care workforce shortages and insufficient access to effective fall prevention and exercise programs, has contributed to a high burden of fall-related injuries in older adults, especially in those with Mild Cognitive Impairment (MCI), a precursor of Alzheimer's dementia (AD) and related dementias (ADRD). There is an urgent need for scalable, evidence-based interventions that can be delivered efficiently in the home setting. This study aims to evaluate the efficacy and impact of a comprehensive digital fall prevention program (Digital STEADI) delivered through a technology platform with two conversational agents that leverage generative artificial intelligence (gen-AI) with human oversight to increase program access, enhance adherence to clinical fall prevention protocols and best practices, and reduce fall risk among community-dwelling older adults.
Who Is on the Research Team?
Madeleine E Hackney, PhD
Principal Investigator
Emory University
Chantal Kerssens, MSc, PhD
Principal Investigator
Friendi.fi Corporation
Are You a Good Fit for This Trial?
This trial is for older adults living at home who have mild cognitive impairment or are at risk of falling. Participants should be able to use digital technology and live independently in the community.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Digital STEADI-1
- Digital STEADI-2
Trial Overview
The study compares a new digital fall prevention program (Digital STEADI) using AI-powered virtual assistants with standard care and other control methods, to see which best reduces falls in older adults with memory or thinking problems.
How Is the Trial Designed?
5
Treatment groups
Experimental Treatment
Active Control
Placebo Group
Cognitively normal participants receiving the intervention via technology.
Cognitively normal participants receiving the intervention via technology.
Participants with mild cognitive impairment receiving the intervention via technology.
Cognitively normal participants receiving the intervention via traditional, non-technological means.
Cognitively normal participants receiving an intervention via traditional, non-technological means.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Friendi.fi Corporation
Lead Sponsor
Emory University
Collaborator
National Institute on Aging (NIA)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.